LabGenomics Co. Ltd (084650) — Capital Reinvestment Ratio
LabGenomics Co. Ltd (084650) has a Capital Reinvestment Ratio of 0.18x as of December 2023, meaning it reinvests 0% of its operating cash flow (₩4.96 Billion) in capital expenditures (₩895.50 Million). Check tangible net worth ratio of LabGenomics Co. Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
LabGenomics Co. Ltd Capital Reinvestment Ratio (2014–2023)
This chart tracks LabGenomics Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see LabGenomics Co. Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for LabGenomics Co. Ltd (2014–2023)
Year-by-year Capital Reinvestment Ratio for LabGenomics Co. Ltd from 2014 to 2023. See free cash flow generation of LabGenomics Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.15x | ₩2.42 Billion | ₩5.20 Billion | ▲ +291.1% |
| 2022 | 0.55x | ₩69.87 Billion | ₩38.33 Billion | ▲ +161.4% |
| 2021 | 0.21x | ₩65.36 Billion | ₩13.72 Billion | ▲ +1291.8% |
| 2020 | 0.02x | ₩46.37 Billion | ₩699.21 Million | ▼ -91.4% |
| 2019 | 0.18x | ₩3.19 Billion | ₩560.94 Million | ▼ -94.7% |
| 2018 | 3.33x | ₩608.03 Million | ₩2.03 Billion | ▲ +108.0% |
| 2016 | 1.60x | ₩2.54 Billion | ₩4.08 Billion | ▼ -17.6% |
| 2015 | 1.95x | ₩2.38 Billion | ₩4.63 Billion | ▲ +409.3% |
| 2014 | 0.38x | ₩3.15 Billion | ₩1.20 Billion | — |